NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
The genetic testing company 23andMe is cutting 40% of its workforce and ending its therapeutics program as its stock price ...
It finished the third quarter with a total of 282.7 million subscribers. — BLOOMBERG NEWS 23andMe is laying off 40 percent of ...
Millions of people have sent their DNA to be analyzed by 23andMe in order to learn their genealogy and risk for certain ...